GlobeImmune - Crunchbase Company Profile & Funding

Q: Who invested in GlobeImmune?

GlobeImmune has 24 investors including SternAegis And Generali Financial Holding.

Q: When was the last funding round for GlobeImmune?

GlobeImmune closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has GlobeImmune raised to date?

GlobeImmune has raised obfuscated.

Overview

GlobeImmune

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About GlobeImmune

CB Rank

2403964

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

Founded

obfuscation

Public

Venture - Series Unknown

Louisville, Colorado, United States

11-50

www.globeimmune.com

Biotechnology

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Richard Duke: Founding Scientist
Donald Bellgrau: Founding Scientist

Details

Legal Name

GlobeImmune Inc.

Operating Status

Active

Stock Symbol

OTCPINK:GBIM

Company Type

For Profit

Founders

Alex Franzusoff, Donald Bellgrau, Richard Duke

About the Company

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated

cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

Phone Number

3036252710

Predictions & Insights

Products & Services

Tarmogen® Platform

A proprietary immunotherapy platform designed to develop treatments for cancer and infectious diseases by activating the immune system.

Research & Development

GlobeImmune is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GlobeImmune	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SternAegis	No	Venture Round - GlobeImmune	—
SternAegis	No	Venture Round - GlobeImmune	—
SternAegis	No	Venture Round - GlobeImmune	—
SternAegis	No	Venture Round - GlobeImmune	—
SternAegis	No	Venture Round - GlobeImmune	—